Open Access

Fluorescent property of 3-hydroxymethyl imidazo[1,2-a]pyridine and pyrimidine derivatives

  • Stephania Velázquez-Olvera1,
  • Héctor Salgado-Zamora1Email author,
  • Manuel Velázquez-Ponce2,
  • Elena Campos-Aldrete3,
  • Alicia Reyes-Arellano3 and
  • Cuauhtémoc Pérez-González4
Chemistry Central Journal20126:83

DOI: 10.1186/1752-153X-6-83

Received: 22 March 2012

Accepted: 6 July 2012

Published: 7 August 2012

Abstract

Background

Imidazo[1,2-a]pyridines and pyrimidines are important organic fluorophores which have been investigated as biomarkers and photochemical sensors. The effect on the luminescent property by substituents in the heterocycle and phenyl rings, have been studied as well. In this investigation, series of 3-hydroxymethyl imidazo[1,2-a]pyridines and pyrimidines were synthesized and evaluated in relation to fluorescence emission, based upon the hypothesis that the hydroxymethyl group may act as an enhancer of fluorescence intensity.

Results

Compounds of both series emitted light in organic solvents dilutions as well as in acidic and alkaline media. Quantitative fluorescence spectroscopy determined that both fused heterocycles fluoresced more intensely than the parent unsubstituted imidazo[1,2-a]azine fluorophore. In particular, 3-hydroxymethyl imidazo[1,2-a]pyridines fluoresced more intensely than 3-hydroxymethyl imidazo[1,2-a]pyrimidines, the latter emitting blue light at longer wavelengths, whereas the former emitted purple light.

Conclusion

It was concluded that in most cases the hydroxymethyl moiety did act as an enhancer of the fluorescence intensity, however, a comparison made with the fluorescence emitted by 2-aryl imidazo[1,2-a]azines revealed that in some cases the hydroxymethyl substituent decreased the fluorescence intensity.

Background

In the past few years a growing interest in the chemistry of imidazo[1,2-a]pyrimidines and pyridines has been developed due to the extent of their applications in pharmacological science. Indeed they are known for their anxiolytic [1], cardiovascular [2], analgesic [3, 4], antihypertensive [4] and neuroleptic [5, 6] among other activities [79]. However, imidazo[1,2-a]pyridines and pyrimidines are also attractive due to their physicochemical properties exhibited, namely the fluorescent activity. Several studies concerning the effects of substituents on the fluorescent properties of imidazo[1,2-apyridines have been carried out, for instance, 2-phenyl (or 2-(2-naphthyl)) and/or 7-methyl substitution caused no deterioration of the fluorescent property. The amino or dimethylamino substitution at the 4'-position of 2-phenyl imidazo[1,2-apyridine shifted the fluorescence to the visible region in polar solvents [10]. From a comparative spectroscopy study performed on several imidazo[1,2-a]pyridines and pyrimidines, it was observed that substitution of a proton for methyl, carboxyl, or amino group increased the fluorescence intensity. Fluorescence was destroyed when a ring position carried a nitro group or when the pyridine or pyrimidine ring is catalytically reduced to the 5,6,7,8-tetrahydro derivative [11]. In the latter study, it was also observed that imidazo[1,2-a]pyrimidines fluoresced more intensely and ca. 60 nm higher than the analogous pyridines. Taking advantage of the fluorescence property, a imidazo1,2-a]pyridine derivative was used as a biomarker of hypoxic tumor cells [12]. A (4-piperidinylfluorophenyl) imidazo1,2-a]pyridine was applied to a multiple fluorescent chemosensor [13]. Recently, an imidazopyrimidine based compound was used in an electron transport layer of an organic light emission device [14].

However, a great disadvantage of many current fluorophores is their very short time of life and susceptibility to physicochemical environments [14], therefore interest in the development of more efficient fluorophores is growing. In this study, the hydroxymethyl group was investigated as an enhancer of the fluorescence property of derivatives of imidazo[1,2-a]pyridines and imidazo[1,2-a]pyrimidines with the aim of obtaining fluorophores with potential use as biomarkers.

Results and discussion

The hydroxymethyl group has proved to be a promoter of fluorescence in naphthyl thioureas [15]. In another study, it was reported that 2-(3,4,5,6-tetrafluoro-2-hydroxyphenyl)imidazo[1,2-a]pyridine emitted long wavelength light around 540 nm both in polar and in nonpolar solvents [16]. Based upon this information, it was hypothesized that introduction of a hydroxymethyl group at position 3 of the imidazo[1,2-a]azines should enhance fluorescence (probably through a spatial non-covalent interaction of the hydroxyl non-bonding electrons with the aryl rings) as compared to the parent fluorophore (the unsubstituted imidazo[1,2-a]azine).

The two series of compounds were prepared straightforward (Scheme 1). Condensation of 2-amino pyridine or 2-amino pyrimidine with the appropriately substituted 2-bromo acetophenone afforded the imidazo[1,2-a]azine nucleus. A Vilsmeier Haack treatment on the fused heterocycles 3 and 4 led to the corresponding 3-formyl substituted derivatives 5. Reduction of the formyl moiety with NaBH4 in alkaline ethyl alcohol delivered the 3-hydroxymethyl derivatives 6 and 7.
Scheme 1

Synthesis of 3-hydroxymethyl imidazo[1,2-a]azines and structures 1, 2 and 8.

Some of these products are already known but have not been studied in relation to a fluorescence property. Products were fully identified by spectroscopic methods and were obtained in moderate to good yields as shown in Tables 1 and 2. New compounds were submitted to combustion analysis for complete characterization.
Table 1

Yields and melting points of 2-aryl-3-hydroxymethyl imidazo[1,2-a]pyridines 6

Compound 6

Aryl

Yield (%)

Mp (°C) Experimental

Mp (°C) Literature*

a

C6H5

70%

202 - 203

>212

b

4’Cl-C6H4

61.3%

229 - 230

>240

c

4’F-C6H4

70.3%

154 - 155

153 - 155

d

4’CH3-C6H4

76.7%

274 - 275

>290

e

4’CH3O-C6H4

66.7%

166 - 167

165 - 167

f

3’,4’di-CH3O-C6H3

71%

171 - 172

170 - 172

g

4’NO2-C6H4

70%

225 - 226

224 – 226

* Reference [17].

Table 2

Yields and melting points of 2-aryl-3-hydroxymethyl imidazo[1,2-a]pyrimidines 7

Compound 7

Aryl

Yield (%)

Mp (°C)

a

C6H5

60.6%

241 – 242*

b

4’Cl-C6H4

63.8%

164 - 165

c

4’F-C6H4

30.3%

232 - 233

d

4’CH3-C6H4

32%

199 - 200

e

4’CH3O-C6H4

86%

187 - 188

f

3’,4’di-CH3O-C6H3

30.4%

200 - 201

g

4’NO2-C6H4

72%

213 - 214

*Compound 2a is mentioned in reference [18], mp is not given.

A series of qualitative assays aimed to evaluate the stability of the products and permanence of the fluorescent property followed: Compound 6 g did not fluoresce. Dilutions of the compounds (0.05 g) in common organic solvents (10 mL) such as ethyl alcohol, acetone, ethyl acetate, acetonitrile and dichloromethane showed fluorescence, this being considerably intense in ethyl acetate and dichloromethane. Solutions of 3-hydroxymethyl imidazo[1,2-a]pyridine 6 and pyrimidine 7 derivatives at various concentrations of aqueous HCl (0.1, 1 and 8 N) preserved the fluorescence, however, this was suppressed with 10 N HCl for the case of imidazo[1,2-a]pyrimidines 7 and deteriorated for the case of 6 at both λ 250 and 365 nm. Addition of weakly acidic materials also preserved fluorescence. Thus, heterogeneous 5% aqueous NH4Cl mixtures of 3-hydroxymethyl 6d showed a decreased fluorescence but 7d preserved it. A powdered mixture of silica gel (0.5 g), for column chromatography thoroughly mixed with the alcohol derivative 7d (10 mg) fluoresced only at the long wavelength λ 365 nm whereas 6d (10 mg) fluoresced at both wavelengths. These results indicate that the protonated species 8 holds the fluorescence activity to a certain extent. Fluorescence of both 6d and 7d in solutions 0.1, 1 and 10 N NaOH gradually diminished but prevailed at both wavelenghts. Biological materials such as egg yolk, pig blood, albumina and Giardia lamblia cultures were fluorescent upon addition of the imidazo[1,2-a]azines. The fluorescence of these products remained after several days.

The quantitative fluorescence analysis performed on one hundred-fold dilutions of the compounds showed that imidazo[1,2-a]pyridines absorbed and emitted energy at long wavelengths (Table 3) while imidazo[1,2-a]pyrimidines absorbed at lower wavelengths but emitted light at longer wavelengths (Table 4).
Table 3

Spectroscopic data for 2-aryl-3-hydroxymethyl imidazo[1,2-a]pyridines 6

 

UV / Vis

Fluorescence

Compound

Aryl

Absλ max(nm)

λ ex (nm)

λ em (nm)

I*

1

---

318

320

376

101.9

6a

C6H5

320

320

381.6

346.91

6b

4’Cl-C6H4

323

320

381

147.17

6c

4’F-C6H4

320

320

380.4

340.42

6d

4’CH3-C6H4

323

320

381.2

306.31

6e

4’CH3O-C6H4

323

320

383.6

884.37

6f

3’,4’di-

CH3O-C6H3

323

320

385.6

878.18

6g

4’NO2-C6H4

347

347

-

-

*I Fluorescence intensities were standardized to a Raman blank methanol solution.

Table 4

Spectroscopic data for 2-aryl-3-hydroxymethyl imidazo[1,2-a]pyrimidines 7

  

UV / Vis

Fluorescence

Compound

Aryl

Absλ max(nm)

λ ex (nm)

λ em (nm)

I*

2

---

229

230

414.8

205.58

7a

C6H5

247

247

437.6

432.44

7b

4’Cl-C6H4

228

228

439.2

53.56

7c

4’F-C6H4

240

240

437.2

542.19

7d

4’CH3-C6H4

240

240

433.6

184.23

7e

4’CH3O-C6H4

226

226

433.6

188.03

7f

3’,4’di-CH3O-C6H3

344

344

432.4

428.32

7g

4’NO2-C6H4

265

265

432

186.43

*I Fluorescence intensities were standardized to a Raman blank methanol solution.

In the case of the imidazo[1,2-a]pyridines 6, all compounds fluoresced more intensely than the parent unsubstituted imidazo[1,2-a]pyridine 1, with the exception of the nitro substituted 6 g, which showed no fluorescence as was expected. It is also worth noting that the 2-(4-chlorophenyl) substituted imidazopyridine derivative 6b showed a rather low intensity.

As for the case of the imidazo[1,2-a]pyrimidine series, again the 2-(4’-chlorophenyl) substituted imidazopyrimidine 7b showed a very low intensity. Surprisingly, the electron donor substituted 7d and 7e and the nitro substituted derivative 7 g registered a similar intensity close to that given by the parent fluorophore 2.

A comparative UV absorption graph for both series of compounds is shown in Figure 1.
Figure 1

UV-Visible absorption spectra of imidazo[1,2-a]azines 6 and 7.

Figure 2 shows a comparison of the emission intensities. From these, it is clearly appreciated that imidazo[1,2-a]pyrimidines emitted light at longer wavelengths than analogous imidazo[1,2-a]pyridines but the latter fluoresced more intensely, in contrast to previous analyses on imidazo[1,2-a[azines [12]. The effects of the phenyl substituents on the outcome of the emission intensities did not follow a consistent pattern, some interesting results are worth pointing out. The strong electron-donating methoxy group caused a marked increased intensity on the imidazopyridine (6e) but not on the imidazopyrimidine (7e). The fluorescence intensity of the imidazo[1,2-a]azines with the phenyl carrying the electron-withdrawing chlorine was low in 6b and dramatically decreased in 7b, whereas the intensity of the derivative with the phenyl bearing the fluorine substituent, 7c was enhanced to make it the most fluorescent of the imidazopyrimidine series. Interestingly in the case of the 4’-nitrophenyl substituted imidazo[1,2-a]pyridine, fluorescence was completely absent, while in the 4’-nitrophenyl substituted imidazo[1,2-a]pyrimidine fluorescence did not vanish.
Figure 2

A comparison of emission wavelengths and intensity of imidazo[1,2-a]azines 6 and 7.

According to the previous results, the role of the hydroxymethyl moiety was not quite clear, therefore we decided to revise the influence of the aryl group on the luminescent response of the 2-aryl imidazo[1,2-a]azines. Results for the 2-aryl imidazo[1,2-a]pyridines 3 (Table 5) showed that the phenyl, as well as the 4’-chloro, 4’-fluoro and 4’-methoxy substituted phenyl increased the fluorescence intensity as compared to 1 and interestingly the 3,4-dimethoxyphenyl caused a drop-off of the intensity. In most cases, the hydroxymethyl group increased fluorescence intensity even more than the aryl substituent, therefore it acted as enhancer. However, the intensity was decreased in the 4’-fluoro substituted phenyl and even more in the case of the 4’-chloro substituted phenyl.
Table 5

Fluorescence data for 2-aryl imidazo[1,2-a]pyridines 3

 

R

UV / Vis

Fluorescence

Compound

Aryl

Absλ max(nm)

λ ex (nm)

λ em (nm)

I*

1

---

318

320

376.0

101-9

3a

C6H5

237

240

375.6

367.8

3b

4’Cl-C6H4

245

245

375.2

310.92

3c

4’F-C6H4

300

300

374

470.34

3e

4’MeO-C6H4

315

315

381.6

407.83

3f

3’,4’diMeO- C6H3

228

230

385.6

178.19

*I Fluorescence intensities were standardized to a Raman blank methanol solution.

As for the case of imdazopyrimidines (Table 6), substitution by phenyl did increase the intensity as compared to the parent fluorophore 2, the 4’-nitro substituted phenyl did not show fluorescence and it was interesting to observe that the 4’-methoxy phenyl (4f) showed a very low intensity. With this information, it was concluded that the hydroxymethyl moiety was a promoter of fluorescence in compound (4 g) and acted as an enhancer of the intensity in all other derivatives except in 2-(4’-chlorophenyl) imidazo[1,2-a]pyrimidine where a decrement was found. Figure 3 shows a comparative graph of the emission wavelengths and fluorescence obtained for compounds 3 and 4.
Table 6

Fluorescence data for 2-aryl imidazo[1,2-a]pyrimidines 4

  

UV / Vis

Fluorescence

Compound

Aryl

Absλ max(nm)

λ ex (nm)

λ em (nm)

I

2

---

229

230

414.8

205.58

4a

C6H5

237

240

429.2

351.98

4b

4’Cl-C6H4

245

245

428.4

334.1

4c

4’F-C6H4

240

240

431.6

355.16

4e

4’MeO-C6H4

240

240

439.2

303.01

4f

3’,4’diMeO-C6H3

222

222

447.6

55.998

4g

4’NO2-C6H4

352

352

---

---

*I Fluorescence intensities were standardized to a Raman blank methanol solution.

Figure 3

A comparison of emission wavelengths and fluorescence intensity for imidazo[1,2-a]pyridines 3 and imidazo[1,2-a]pyrimidines 4.

Thermal properties

The thermal stability of the most fluorescent compounds, 6a, 6e, 6f, 7a, 7c and 7f was estimated through a thermo gravimetric analysis (TGA) within an interval 0 – 600°C under an inert atmosphere. From the TG curves shown in Figure 4 it was determined that these compounds were thermally stable up to 280°C. The thermodynamic most stable was 7f, which completely decomposed above 600°C (47.75% mass loss at 600°C). The chemically most stable was 6f (55.25% weight loss at 600°C) and compound 7a showed a 66.47% weight loss at 600°C, the least stable was 6a (95.25% weight loss at 600°C).
Figure 4

Thermogravimetric analysis of selected 3-hydroxymethyl imidazo[1,2-a]pyridine and pyrimidine derivatives.

Experimental

Melting points were measured on an Electrothermal melting point apparatus and are uncorrected. The FT-IR spectra were recorded on Perkins-Elmer 257 spectrometer using KBr discs. 1 H and 13C nmr spectral data were recorded with a Varian Mercury 300 MHz or a Varian 500 spectrometer. The chemical shifts (δ) are referenced to internal (CH3)4Si (δ 1 H = 0, δ 13C = 0). Fluorescence measurements were performed with a Shimadzu spectrofluorophotometer (RF-5000), equipped with a 150-W Xenon lamp, 12” color video display, 1 x 1 cm quartz cells. Both, operational performance and instrument sensitivity were revised by running a Raman spectrum of methanol. Cells were mounted in the holding device. The cell was filled out with a dilution 1:100 of the compounds in question for various lengths and then washed four times with methanol. Thermo gravimetric analysis was performed on a TGA 2950 Thermogravimetric Analyzer TA Instruments in a range 0-600°C, at a rate of 10°C/min on a platinum tray, under a nitrogen atmosphere and a flux rate 37.5 and 25.

General procedure for the synthesis of 3-hydroxymethyl imidazo[1,2-a]pyridines and pyrimidines

In a round bottom flask equipped with a magnetic stirrer, 1 g of the formyl derivative was suspended in ethanol (30 mL). The mixture was heated to 30°C and NaBH4 dissolved in 2 mL of 0.1 N NaOH added (2 molar equivalents for imidazo[1,2-a]pyridine and 1 molar equivalent for imidazo[1,2-a]pyrimidine). The reaction mixture was left stirring and reaction progress monitored by thin layer chromatography. After completion, ethanol was removed under vacuum. The solid formed was re-suspended in water and concentrated HCl added dropwise to neutral pH. The solid was collected by filtration, washed with water and dried off with hexane.

2-Phenyl-3-hydroxymethy imidazo[1,2-a]pyridine 6a

IR υ max cm-1: 3290 (OH); 2966.57, 2916.51, 2848.34 (C-H); 1734.11 (C=C).

1H NMR (300MHz, DMSO-d6) δ: 8.46 (1H, dd, J5,6=6.9, J5,7=1.2, H5); 7.84 (2H, d, J2’,3’=6.9, H2’,6’); 7.61 (1H, dd, J8,7=8.1, J8,6=1.2, H8); 7.48 (2H, td, J3’,2’=6.9, J3’,4’=7.2, J3’,5’=1.6 H3’,H5’); 7.38 (1H, td, J4’,3’=7.2, J4’,2’=1.6 H4’); 7.3 (1H, td, J7,8=8.1, J7,6=6.9, J7,5=1.2, H7); 6.98 (1H, td, J6,5=6.9, J6,7=6.9, J6,8=1.2, H6); 5.44 (1H, s, OH); 4.92 (2H, s, CH2).

13C NMR (75.5MHz, DMSO-d6) δ: 143.9 (C5), 142.8 (C8a); 134.3 (C1’), 128.4 (C2’); 128.1 (C3’); 128.2 (C4’); 124.8 (C7); 120.4 (C3); 116.6 (C8); 111.9 (C6); 52.8 (CH2).

2-(4’-Chlorophenyl)-3-hydroxymethyl imidazo[1,2-a]pyridine 6b

Isolated as a white solid in 61.3% yield, mp 229 - 230ºC (Lit 15, mp >240°C).

IR υ max cm-1: 3398 (OH); 2930 (C-H); 1635 (C=C).

1H NMR (300MHz, DMSO-d6) δ: 8.46 (1H, d, J5,6=6.9, H5); 7.87 (2H, d, J2’,3’=8.8, H2’); 7.6 (1H, d, J8,7=9.0, H8); 7.52 (2H, d, J3’,2’=8.8, H3’,5’); 7.31 (1H, td, J7,8=9.0, J7,6=6.8, J7,5=1.2, H7); 6.98 (1H, td, J6,5=6.9, J6,7=6.8, J6,8=1.2, H6); 5.47 (1H, t, J=4.8, OH); 4.92 (2H, d, J=4.8, CH2).

13C NMR (125MHz, DMSO-d6) δ: 143.9 (C5); 142.8 (C8a); 134.3 (C1’); 128.4 (C2’); 128.1 (C3’); 128.2 (C4’); 125.0 (C2); 124.8 (C7); 120.4 (C3); 116.6 (C8); 111.9 (C6); 52.8 (CH2).

2-(4’-Fluorophenyl)-3-hydroxymethyl imidazo[1,2-a]pyridine 6c

Isolated as a white solid in 70.3% yield, mp 154 - 155ºC (Lit 15, mp 153 - 155°C).

IR υ max cm-1: 3427 (OH); 3137 and 3048 (C-H); 1600 (C=C).

1H NMR (300MHz, DMSO-d6) δ: 8.52 (1H, d, J5,6=6.9, H5); 8.0 (2H, dd, J2’,3’=9.0, Jm=5.7, H2’ and H6’); 7.57 (1H, d, J8,7=9.3, H8); 7.37 – 7.29 (3H, m, H7,3’,5’); 6.87 (1H, d, J6,5=6.9, H6); 5.54 (1H, s, OH); 4.91 (2H, s, CH2).

13C NMR (125MHz, DMSO-d6) δ: 163.4 and 161.0 (C4); 143.91 (C8a); 130.9 and 130.8 (C2); 125.1 (C1); 120.4 (C3); 116.6 (C8); 115.6 and 115.3 (C3); 112.1 (C6); 52.0 (CH2).

2-(4’-Methylphenyl)-3-hydroxymethyl imidazo[1,2-a]pyridine 6d

Isolated as a white solid in 76.7% yield, mp 274 - 275ºC (Lit 15, mp >290°C).

IR υ max cm-1: 3279 (OH); 3040 y aprox 2950 (C-H); 1654 (C=C).

1H NMR (500MHz, DMSO-d6) δ: 8.45 (1H, d, J5,6=6.9, H5); 7.74 (2H, d, J2’,3’=9.0, H2’,6’); 7.61 (1H, d, J8,7=9.3, H8); 7.33 – 7.28 (3H, m, H7,3’.5’); 6.98 (1H, dd, J6,5=6.9, J6,7=6.9, H6); 5.45 (1H, t, J=5.1, OH); 4.91 (2H, d, J=5.1, CH2); 2.36 (3H, s, CH3).

13C NMR (125MHz, DMSO-d6) δ: 143.9 (C5); 142.9 (C8a); 136.9 (C1’); 131.6 (C4’); 129.1 (C3’); 128.1 (C2’); 125.1 (C2); 124.9 (C7); 120.2 (C3); 116.5 (C8); 112.0 (C6); 52.2 (CH2); 20.8 (CH3).

2-(4’-Methoxyphenyl)-3-hydroxymethyl imidazo[1,2-a]pyridine 6e

Isolated as a white solid in 66.7% yield, mp 166 - 167ºC (Lit 15, mp 165 - 167°C).

IR υ max cm-1: 3427 (OH); ca. 2950 (C-H); 1610 (C=C).

1H NMR (300MHz, DMSO-d6) δ: 8.43 (1H, dd, J5,6=6.9, J5,7=1.5 H5); 7.77 (2H, d, J2’,3’=9.0, H2’,6’); 7.57 (1H, d, J8,7=9.0, H8); 7.28 (1H, td, J7,8=9.0, J7,6=6.6, J7,5=1.5, H7); 7.04 (2H, d, J3’,2’=9.0, H3’,5’); 6.95 (1H, d J6,7=6.6, H6); 5.37 (1H, d, J=5.1, OH); 4.9 (2H, d, J=5.1, CH2); 3.82 (3H, s, OCH 3 ).

13C NMR (75.5MHz, DMSO-d6) δ: 157 (C4’); 141.9 (C5); 140.9 (C8a); 127.4 (C2’); 124.9 (C4); 123 (C1’); 122.7 (C2’); 117.8 (C3); 114.5 (C8); 112 (C3’); 109.8 (C6); 53.2 (CH2).

2-(3’,4’-Dimethoxyphenyl)-3-hydroxymethyl imidazo[1,2-a]pyridine 6f

Isolated as a brown solid in 71% yield, mp 171 - 172ºC (Lit 15, mp 170 - 172°C).

IR υ max cm-1: 3004.19 (OH); 2933.8 and 2834.93 (C-H); 1633.76 (C=C).

1H NMR (500MHz, DMSO-d6) δ: 8.46 (1H, d, J5,6=7.2 H5); 8.44 (1H, dd, J8,7=7.0, J8,6=1.6, H7); 7.61 (1H, d, J2’,6’=1.2, H2’); 7.56 (1H, dd, J6’,5’=6.4, J6’,2’=1.2 H6’); 7.50 (1H, dd, J7,8=7.0, J7,5=1.6 H7); 6.9 (1H, d, J5’,6’=8.0, H5’); 6.8(1H, td, J6,5=7.2, J6,7=7.2 J6,8=1.2 H6) ; 5.4 (1H, s, OH); 4.9 (2H, s, CH2); 3.83 (3H, s, OCH3), 3.81, (3H, s, OCH3).

13C NMR (125MHz, DMSO-d6) δ: 148.7 (C7); 148.5 (C4’); 143.7 (C3’); 142.9 (C8a); 127.03 (C2); 124.6 (C5); 120.4 (C1’); 119.8 (C6’); 116.4 (C3); 111.8 (C2’ and C5’); 111.7 (C6), 55.46 and 55.38 (OCH3); 52.1 (CH2).

2-(4’-Nitrophenyl)-3-hydroxymethyl imidazo[1,2-a]pyridine 6g

Isolated as a yellow solid in 70% yield, mp 225 - 226ºC (Lit 15, mp 224 - 226°C).

IR υ max cm-1: 3417 (OH); 3130, 2943 (C-H); 1600 (C = C).

1 H NMR (300 MHz, DMSO-d6) δ: 8.5 (1 H, d, J5,6 = 6.9); 8.49 (2 H, d, J2’,3’ = 8.9); 8.14 (2 H, d, J2’,3’ = 8.9); 7.62 (1 H, d, J7,8 = 9.0); 7.34 (1 H, ddd, J5,7 = 1.2, J6,7 = 6.9, J7,8 = 9.0); 7.0 (1 H, ddd, J6,8 = 1.2, J5,6 = 6.9, J6,7 = 6.9); 5.55 (1 H, t, J = 5.1, OH); 4.98 (2 H, d, J = 5.1, CH2).

13C NMR (125MHz, DMSO-d6) δ: 146.3 (C5); 144.2 (C8a); 140.8 (C1); 140.3 (C3); 128.6 (C3’); 125.4 (C4’); 125.0 (C2); 123.4 (C2’); 122.2 (C7); 116.8 (C8); 112.3 (C6); 52.0 (CH2).

2-Phenyl-3-hydroxymethyl imidazo[1,2-a]pyrimidine 7a

Isolated as a yellow solid in 60.6% yield, mp 241 - 242ºC.

IR υ max cm-1: 3216 (OH); 3082, 2948 y 2884 (C-H); 1614 (C=C).

1H NMR (300MHz, DMSO-d6) δ: 8.92 (1H, dd, J5,6=6.9, J5,7=1.2, H5); 7.84 (2H, d, J2’,3’=6.9, H2’,6’); 7.61 (1H, dd, J7,6=8.1, J7,5=1.2, H7); 7.53 (2H, dd, J3’,2’=6.9, J3’,4’=7.2, H3’,5’); 7.4 (1H, dd, J4’,3’=7.2, H4’); 7.1 (1H, td, J6,5=6.9, J6,7=6.9, J6,8=1.2, H6); 5.45 (1H, s, OH); 4.96 (2H, s, CH2).

13C NMR (75.5MHz, DMSO-d6) δ: 150.5 (C5), 147.2 (C8a); 143.6 (C1’), 133.8 (C2’); 128.6 (C3’); 128.3 (C4’); 128 (C7); 119.2 (C3); 108.6 (C8); 111.9 (C6); 51.8 (CH2).

Anal. calcd for C13H11N3O: C, 69.33 H, 4.88, N, 18.76; found: C, 69.41, H, 5.2, N, 18.46.

2-(4’-Chlorophenyl)-3-hydroxymethyl imidazo[1,2-a]pyrimidine 7b

Isolated as a yellow solid in 63.8% yield, mp 164 - 165ºC.

IR υ max cm-1: 3400 - 1900 (OH and C-H); 1662 and 1618 (C=C).

1H NMR (500MHz, DMSO-d6) δ: 8.97 (1H, d, J5,6=7.0, H5); 8.61 (1H, dd, J7,6=4.0, J7,5=2.0, H7); 7.91 (2H, d, J2’,3’=8.5, H2’,6’); 7.58 (2H, dd, J3’,2’=8.5, H3’,5’); 7.15 (1H, dd, J6,5=7.0, J6,7= 4.0, H6); 5.65 (1H, s, OH); 4.92 (2H, s, CH2).

13C- NMR (125MHz, DMSO-d6) δ: 150.6 (C7); 147.2 (C8a); 142.2 (C2); 133.6 (C5); 132.8 (C1’); 132.6 (C4’); 129.9 (C2’); 128.7 (C3’); 119.4 (C6); 108.7 (C3); 56.0 (CH2).

Anal. calcd for C13H10N3OCl: 60.11 H, 3.85, N, 16.19; found: C, 60.23, H, 4.01, N, 15.92.

2-(4’-Fluorophenyl)-3-hydroxymethyl imidazo[1,2-a]pyrimidine 7c

Isolated as a yellow solid in 30.3% yield, mp 232 - 233ºC.

IR υ max cm-1: 3300 (OH); 3076 (C-H); 1659 and 1615 (C=C).

1H NMR (500MHz, DMSO-d6) δ: 9.01 (1H, dd, J5,6=6.5, J5,7=2.0, H5); 8.59 (1H, dd, J7,6=4.0, J7,5=2.0, H7); 7.92 (2H, dd, J2’,3’=12.0, J2’F=5.0, H2’); 7.34 (2H, dd, J2’,3’=12.0, J3’F=9.0, H3’); 7.14 (1H, dd, J6,7=4.0, J6,5=6.5 H6); 5.72 (1H, s, OH); 4.9 (2H, s, CH2).

13C NMR (125MHz, DMSO-d6) δ: 163.4 and 161.0 (C4); 150.4 (C7); 147.0 (C8a); 142.4 (C2); 133.6 (C5); 130.2 (C2’); 130.1 (C1’); 119.2 (C6); 115.6 and 115.4 (C3’); 108.6 (C3); 51.5 (CH2).

Anal. calcd for C13H10N3OF: 64.19 H, 4.11, N, 17.28; found: C, 65.26, H, 4.23, N, 16.98.

2-(4’-Methylphenyl)-3-hydroxymethyl imidazo[1,2-a]pyrimidine 7d

Isolated as a yellow solid in 32% yield, mp 199 - 200ºC.

IR υ max cm-1: 3369 (OH); 2926 (C-H); 1617 (C=C).

1H NMR (500MHz, DMSO-d6) δ: 8.99 (1H, dd, J5,6=6.5, J5,7=1.5, H5); 8.59 (1H, dd, J7,6=7.0, J7,5=1.5, H7); 7.9 (2H, d, J2’,3’=8.0, H2’,6’) 7.57 (2H, d, J3’,2’=8.0, H3’,5’); 7.13 (1H, dd, J6,7=7.0, J6,5=6.5, H6); 5.7 (1H, s, OH); 4.91 (2H, s, CH2); 3.38 (3H, s, CH3).

13C NMR (125MHz, DMSO-d6) δ: 150.7 (C7); 147.1 (C8a); 142.2 (C2); 133.6 (C5); 132.7 (C1’); 132.7 (C4’); 129.8 (C3’); 128.6 (C2’); 119.6 (C6); 108.6 (C3); 55.9 (CH2); 51.5 (CH3).

Anal. calcd for C14H13N3O: 70.29 H, 5.39, N, 17.57; found: C, 70.13, H, 5.51, N, 17.38.

2-(4’-Methoxyphenyl)-3-hydroxymethyl imidazo[1,2-a]pyrimidine 7e

Isolated as a yellow solid in 86% yield, mp 187 - 188ºC.

IR υ max cm-1: 3409 (OH); aprox 2900 (C-H); 1617 (C=C).

1H NMR (500MHz, DMSO-d6) δ: 8.95 (1H, dd, J5,6=6.5, J5,7=2.0, H5); 8.56 (1H, dd, J7,6=4.0, J7,5=2.0, H7) 7.82 (2H, d, J2’,3’=8.5, H2’,6’); 7.12 (1H, dd, J6,5=6.5, J6,7=4.0, H6); 7.08 (2H, dd, J3’,2’=8.5, H3’,5’); 5.62 (1H, s, OH); 4.9 (2H, s, CH2); 3.83 (3H, s, OCH3).

13C NMR (125MHz, DMSO-d6) δ: 159.2 (C4’); 149.9 (C7); 147.1 (C8a); 143.6 (C2); 133.3 (C5); 129.5 (C2’); 118.4 (C6); 114.1 (C3’); 108.3 (C3); 55.2 (CH2) 51.7 (OCH 3 ).

Anal. calcd for C14H13N3O2: 65.88 H, 5.09, N, 16.47; found: C, 65.66, H, 4.80, N, 16.29.

2-(3’,4’-Dimethoxyphenyl)-3-hydroxymethyl imidazo[1,2-a]pyrimidine 7f

Isolated as a brown solid in 30.4% yield, mp 200 - 201ºC.

IR υ max cm-1: 3397 (OH); 3083, 2994 and 2937 (C-H); 1615 (C=C).

1H NMR (500MHz, DMSO-d6) δ: 8.97 (1H, d, J5,6=4.0, H5); 8.56 (1H, d, J7,6=2.0, H7); 7.49 (1H, d, J2’,6’=2.0, H2’); 7.42 (1H, d, J6’,5’=8.0, H6’); 7.09 (2H, m, H5’,6); 5.46 (1H, s, OH); 4.93 (2H, s, CH2); 3.8 (6H, s, OCH3).

13C NMR (125MHz, DMSO-d6) δ: 149.9 (C7); 148.8 (C4’); 148.7 (C3’); 147.0 (C8a); 143.7 (C2); 133.3 (C5); 126.4 (C1’); 120.7 (C6’); 118.6 (C3); 111.8 (C2’ and C5’); 108.6 (C6), 55.5 and 55.4 (OCH3); 51.7 (CH2).

Anal. calcd for C15H15N3O3: 63.15 H, 5.26, N, 14.73; found: C, 63.01, H, 5.17, N, 14.44.

2-(4’-Nitrophenyl)-3-hydroxymethyl imidazo[1,2-a]pyrimidine 7g

Isolated as a yellow solid in 72% yield, mp 213 - 214ºC.

IR υ max cm-1: 3376 (OH); 2933 (C-H); 1675 (C=C).

1H NMR (300MHz, DMSO-d6) δ: 8.64 (1H, t, J5,6=6.9, J5,7=1.2, H5); 8.34 (2H, dd, J2’,3’=8.7, H3’); 8.15 (2H, d, J2’,3’=8.7, H2’); 7.1 (1H, dd, J6,8=1.2, J7,8=9.0, H8); 6.15 (1H, dd, J5,7=1.2, J6,7=6.6, J7,8=9.0, H7); 5.59 (1H, d, J6,8=1.2, H8); 4.9 (1H, t, J5,7=1.2, J6,7=6.6, J7,8=9.0, H7); 3.32 (1H, t, J5,6=6.9, J6,7=6.6, J6,8=1.2, H6); 2.9 (1H, d, J=5.1, OH); 2.4 (2H, d, J=5.1, CH2).

13C NMR (125MHz, DMSO-d6) δ: 152.7 (C5); 148.6 (C8a); 148.06 (C1); 142.3 (C3); 141.6 (C3’); 135.2 (C4’); 125.0 (C2); 130.3 (C2’); 125.2 (C7); 122.6 (C8); 110.3 (C6); 52.88 (CH2).

Anal. calcd for C13H10N4O3: 57.77 H, 3.70, N, 20.74; found: C, 57.56, H, 3.85, N, 20.62.

Conclusion

2-Aryl-3-hydroxymethyl imidazo[1,2-a]pyridines and 2-aryl-3-hydroxymethyl imidazo[1,2-a]pyrimidines emitted light at long wavelengths more intensely than the respective non-substituted imidazo[1,2-a]pyridine and pyrimidine fluorophores. The hydroxymethyl group was an enhancer of the fluorescence intensity of the 2-aryl imidazo[1,2-a]azines, although in some cases it caused a decrement of the luminescent activity. These findings indicate that an interplay of the electronic character of the phenyl substituents with the hydroxymethyl moiety is most probably operating. The thermogravimetric analysis on selected most fluorescent imidazo[1,2-a]azines, indicated that they are thermally stable up to 280°C. Other studies aimed to decide if the herein investigated compounds are suitable as effective fluorescent dyes in biological applications are currently underway.

Declarations

Acknowledgements

We thank Consejo Nacional de Ciencia y Tecnología Mexico for financial support through project 49937. We are grateful to Dr. Armando Gómez Poyou, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México for the fluorometric measurements. Special thanks to Miguel Angel Canseco Martínez, Investigación en Materiales, Universidad Nacional Autónoma de México for the thermogravimetric study. SVO thanks Consejo Nacional de Ciencia y Tecnología for graduate scholarship No. 257526.

Authors’ Affiliations

(1)
Departamento Química Orgánica. Escuela Nacional Ciencias Biológicas, Instituto Politécnico Nacional
(2)
Departamento de formación básica disciplinaria Instituto Politécnico Nacional, Mineral de Valenciana No 200 Fraccionamiento Industrial Puerto Interior
(3)
Departamento Química Orgánica. Escuela Nacional Ciencias Biológicas, Instituto Politécnico Nacional
(4)
Departamento de Sistemas Biológicos, Universidad Autónoma Metropolitana Xochimilco

References

  1. Dusza HP, Albright JD: U.S. 5, 037, 980(Cl. 544–281, CO 7D 487/ 04), 06 Aug. 1991 Appl. 182, 650, 18 Avr. 1988. Chem Abstr. 1991, 115: 256202q-Google Scholar
  2. Okabe T, Bhooshan B, Novinson T, Hillyard IW, Garner GE, Robins RK: Dialkyl bicyclic heterocycles with a bridgehead nitrogen as purine analogs possessing significant cardiac inotropic activity. J Heterocyclic Chem. 1983, 20: 735-751. 10.1002/jhet.5570200345.View ArticleGoogle Scholar
  3. Stachle H, Kummer W, Koppe H: Ger. Offen. 1974, 2, 234, 622 (Cl. CO 7D), 31 Jan. Appl. 22, 34622. 1, 14 Jun. 1972. Chem Abstr. 1974, 80: 120993z-Google Scholar
  4. Stachle H, Kummer W, Koppe H: Ger. Offen. 1983, DE 3, 124, 718(Cl. CO 7D 487/04), 13 Jan. Appl P 24 Jun. 1981. Chem. Abstr. 1983, 114: 126153u-Google Scholar
  5. Stachle H, Kummer W, Koppe H: Ger. Offen. 1972, 2, 109, 524(Cl. CO7D), 07 Sep. Appl. 21 09524 9, 01 Mar.1971. Chem Abstr. 1972, 77: 164750 k-Google Scholar
  6. Yashiano T, Tadashi M: Eur. Pat. 1985, Appl. EP 163, 240 (Cl. CO 7D 487/ 04), 04 Dec, JP. Appl. 84/ 104, 257, 22 Mai.1984. Chem Abstr. 1986, 104: 186438 t-Google Scholar
  7. El Kazzouli S, Griffon Du Bellay A, Berteina-Raboin S, Delagrange P, Caignard D-H, Guillaumet G: Design and synthesis of 2-phenylimidazo[1,2-a]pyridines as a novel class of melatonin receptor ligands. Eur J Med Chem. 2011, 46: 4252-4257. 10.1016/j.ejmech.2011.06.030.View ArticleGoogle Scholar
  8. Gong Y-D, Cheon HG, Lee T, Kang NS: A novel 3-(8-chloro-6-(trifluoromethyl)imidazo[1,2-a]pyridine-2-yl)phenyl acetate skeleton and pharmacophore model as glucagon-like peptide 1 receptor agonists. Bull Korean Chem Soc. 2010, 31: 3760-3764. 10.5012/bkcs.2010.31.12.3760.View ArticleGoogle Scholar
  9. Koubachi J, El Kazzouli S, Berteina-Raboin S, Mouaddib A, Guillaumet G: Synthesis of polysubstituted imidazo[1,2-a]pyridines via microwave-assisted one-pot cyclization/Suzuki coupling/palladium-catalyzed heteroarylation. J Org Chem. 2007, 72: 7650-7655. 10.1021/jo0712603.View ArticleGoogle Scholar
  10. Tomoda H, Hirano T, Saito S, Mutai T, Araki K: Substituent Effects on Fluorescent Properties of Imidazo[1,2-a]pyridine-Based Compounds. Bull Chem Soc Jpn. 1999, 72: 1327-1334. 10.1246/bcsj.72.1327.View ArticleGoogle Scholar
  11. Rackham DM: Spectroscopic Studies of Some Imidazo[1,2-a]pyridine and Imidazo[1,2-a]pyrimidine Derivatives. Appl Spectroscopy. 1979, 33: 561-563. 10.1366/0003702794925129.View ArticleGoogle Scholar
  12. Hodgkiss RJ, Middleton RW, Parrick J, Rami HK, Wardman P, Wilson GD: Bioreductive fluorescent markers for hypoxic cells: A study of 2-nitroimidazoles with 1-substituents containing fluorescent, bridgehead-nitrogen, bicyclic systems. J Med Chem. 1920, 1992: 35-Google Scholar
  13. Kurushima T, Iwata S, Tanaka K: Application of (4-piperidinylfluorophenyl)imidazopyridine to a multiple fluorescence chemosensor. Nippon Kagakkai Koen Yokoshu. 2006, 86: 1473-Google Scholar
  14. Hee-Yeon K, Seung-Gak Y, Jung-Han S, Chang-Ho L, Hee-Joo K: Imidazopyrimidine-based compound and organic light-emitting device employing organic layer including the same. 2008, US20080226945A1, 18 SepGoogle Scholar
  15. Xuhong Q, Fengyu L: Promoting effects of the hydroxymethyl group on the fluorescent signaling recognition of anions by thioureas. Tetrahedron Lett. 2003, 44: 795-799. 10.1016/S0040-4039(02)02671-0.View ArticleGoogle Scholar
  16. Kiyoshi T, Tohru K, Satoru I, Syunsuke S: Fluorescent behavior of 2-(3,4,5,6-tetrafluoro-2-hydroxyphenyl)imidazo-[1,2-a]pyridine in the presence of metal perchlorate. J Heterocycl Chem. 2007, 44: 303-307. 10.1002/jhet.5570440204.View ArticleGoogle Scholar
  17. Nilsson M, Haraldsson M, Henriksson S, Emond R, Savory E, Simpson I: Imidazopyridine Compounds. 2010, WO2010064020A1, 10 JunGoogle Scholar
  18. Anaflous A, Benchat N, Mimouni M, Abouricha S, Ben-Hadda T, El-Bali B, Hakkou A, Hacht B: Armed imidazo[1,2-a]pyrimidines (pyridines): Evaluation of antibacterial activity. Lett Drug Des Discov. 2004, 1: 224-229. 10.2174/1570180043398885.View ArticleGoogle Scholar

Copyright

© Velázquez-Olvera et al.; licensee Chemistry Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.